ArticleOncoTargets and therapy2013

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX.

Eriko Takatori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.